Active Ingredient: DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
Proprietary Name: QTERN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG;EQ 5MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209091
Product Number: 001
Approval Date: Feb 27, 2017
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:
Prescription
Patent and Exclusivity Information
